Hirofumi Hanaoka

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 13

Top Topics

Rheumatoid Arthritis

Small Cell Lung Cancer

Lipopolysaccharide Induced

Top Venues

Annals of nuclear medicine

Molecular pharmaceutics

Bioconjugate chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Hirofumi Hanaoka, Kazuyuki Hashimoto, Satoshi Watanabe, Shojiro Matsumoto, Tetsuya Sakashita, Shigeki Watanabe, Noriko S Ishioka, Keigo Endo
Comparative evaluation of radionuclide therapy using 90 Y and 177 Lu. Annals of nuclear medicine (2022)
Wenchao Gu, Ryan Yudistiro, Hirofumi Hanaoka, Natsumi Katsumata, Yoshito Tsushima
Potential of three-step pretargeting radioimmunotherapy using biotinylated bevacizumab and succinylated streptavidin in triple-negative breast cancer xenograft. Annals of nuclear medicine 35 (4) (2021)
Tomoya Uehara, Naoki Kanazawa, Chie Suzuki, Yuki Mizuno, Hiroyuki Suzuki, Hirofumi Hanaoka, Yasushi Arano
Renal Handling of 99mTc-Labeled Antibody Fab Fragments with a Linkage Cleavable by Enzymes on Brush Border Membrane. Bioconjugate chemistry 31 (11) (2020)
Aiko Yamaguchi, Hirofumi Hanaoka, Tetsuya Higuchi, Yoshito Tsushima
Selective synthesis of L-2-[18 F]fluoro-alpha-methylphenylalanine via copper-mediated 18 F-fluorination of (mesityl)(aryl)iodonium salt. Journal of labelled compounds & radiopharmaceuticals 63 (8) (2020)
Trang Thuy Dam, Hirofumi Hanaoka, Takahito Nakajima, Aiko Yamaguchi, Koichi Okamura, Hirotaka Chikuda, Yoshito Tsushima
64Cu-ATSM and 99mTc(CO)3-DCM20 potential in the early detection of rheumatoid arthritis. Modern rheumatology 31 (2) (2020)
Citra R A P Palangka, Hirofumi Hanaoka, Aiko Yamaguchi, Takashi Murakami, Yoshito Tsushima
Al18F-labeled alpha-melanocyte-stimulating hormone (α-MSH) peptide derivative for the early detection of melanoma. Annals of nuclear medicine 33 (10) (2019)
Hirofumi Hanaoka, Yasuhiro Ohshima, Aiko Yamaguchi, Hiroyuki Suzuki, Noriko S Ishioka, Tetsuya Higuchi, Yasushi Arano, Yoshito Tsushima
Novel 18F-Labeled α-Methyl-Phenylalanine Derivative with High Tumor Accumulation and Ideal Pharmacokinetics for Tumor-Specific Imaging. Molecular pharmaceutics 16 (8) (2019)
Aiko Yamaguchi, Arifudin Achmad, Hirofumi Hanaoka, Yusri Dwi Heryanto, Anu Bhattarai, null Ratianto, Erdene Khongorzul, Rini Shintawati, A Adhipatria P Kartamihardja, Ayaka Kanai, Yumi Sugo, Noriko S Ishioka, Tetsuya Higuchi, Yoshito Tsushima
Immuno-PET imaging for non-invasive assessment of cetuximab accumulation in non-small cell lung cancer. BMC cancer 19 (1) (2019)
Yuichiro Taira, Tomoya Uehara, Masao Tsuchiya, Hideaki Takemori, Yuki Mizuno, Shiori Takahashi, Hiroyuki Suzuki, Hirofumi Hanaoka, Hiromichi Akizawa, Yasushi Arano
Coordination-Mediated Synthesis of Purification-Free Bivalent 99mTc-Labeled Probes for in Vivo Imaging of Saturable System. Bioconjugate chemistry 29 (2) (2018)
Ryan Yudistiro, Hirofumi Hanaoka, Natsumi Katsumata, Aiko Yamaguchi, Yoshito Tsushima
Bevacizumab Radioimmunotherapy (RIT) with Accelerated Blood Clearance Using the Avidin Chase. Molecular pharmaceutics 15 (6) (2018)
Huong Nguyen-Thu, Hirofumi Hanaoka, Takahito Nakajima, Aiko Yamaguchi, Tien Nguyen-Cong, A Adhipatria P Kartamihardja, Yoshito Tsushima
Early prediction of triple negative breast cancer response to cisplatin treatment using diffusion-weighted MRI and 18F-FDG-PET. Breast cancer (Tokyo, Japan) 25 (3) (2018)
Ayaka Shinohara, Hirofumi Hanaoka, Tetsuya Sakashita, Tatsuhiko Sato, Aiko Yamaguchi, Noriko S Ishioka, Yoshito Tsushima
Rational evaluation of the therapeutic effect and dosimetry of auger electrons for radionuclide therapy in a cell culture model. Annals of nuclear medicine 32 (2) (2017)
Yusri-Dwi Heryanto, Hirofumi Hanaoka, Takahito Nakajima, Aiko Yamaguchi, Yoshito Tsushima
Applying near-infrared photoimmunotherapy to B-cell lymphoma: comparative evaluation with radioimmunotherapy in tumor xenografts. Annals of nuclear medicine 31 (9) (2017)